Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Background: Complex local and systemic immune dysfunction in glioblastoma (GBM) may affect survival. Interleukin (IL)-6 and YKL-40 are pleiotropic biomarkers present in the tumor microenvironment and involved in immune regulation. We therefore analyzed plasma IL-6, YKL-40, and genetic variation in Y...

Descripción completa

Detalles Bibliográficos
Autores principales: Holst, Camilla Bjørnbak, Christensen, Ib Jarle, Skjøth-Rasmussen, Jane, Hamerlik, Petra, Poulsen, Hans Skovgaard, Johansen, Julia Sidenius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180208/
https://www.ncbi.nlm.nih.gov/pubmed/32363159
http://dx.doi.org/10.3389/fonc.2020.00478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180208/
https://www.ncbi.nlm.nih.gov/pubmed/32363159
http://dx.doi.org/10.3389/fonc.2020.00478

Ejemplares similares